diate early gene activation after SAH is already being investigated. 2, 10, 28 It will be important to identify the substances that induce changes in gene expression after SAH because this may lead to a better understanding of the pathophysiological mechanisms of vasospasm. In addition, some potential therapies for stroke, such as those directed against apoptosis, alter gene expression and will, therefore, require an understanding of the pathophysiological changes in gene expression that accompany stroke. 2, 10, 28 We chose to study the effects of erythrocyte hemolysate because of evidence indicating that hemolysate, in conjunction with the hemoglobin contained in it, is the component of blood that is the most important cause of vasospasm. 20 Fresh erythrocyte hemolysate increases intracellular calcium in freshly isolated rat basilar artery smooth-muscle cells by inducing a release of calcium from intracellular stores and by causing a secondary influx of extracellular calcium. 37 Our investigations revealed that adenosine triphosphate (ATP) produced a calcium release and influx identical to that produced by hemolysate and suggested that ATP is the vasoactive component of hemolysate, at least in short-term calcium imaging studies in vitro. 37, 38 These findings led us to investigate effects of hemoglobin and ATP on gene expression and to compare their effects to whole hemolysate to determine whether these are the active components of hemolysate.
Materials and Methods

Cell Culture
Rat aortic smooth-muscle cells were grown in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum, 100 U/ml penicillin and 0.1 mg/ml streptomycin. 17 Confluent cells were growth arrested in serum-free medium for 18 to 24 hours before any treatment.
Preparation of Hemolysate and Components
Hemolysate was prepared by hypotonic lysis of freshly washed dog erythrocytes. 26, 37 Concentrated hemolysate was obtained by centrifugation in a vacuum for 6 hours until it reached one third of the original volume. Insoluble proteins were removed by centrifugation at 14,000 G, and the supernatant was sterilized by filtration and stored at Ϫ80˚C. The hemoglobin and ATP concentrations of the hemolysate were determined by spectrophotometry and high-pressure liquid chromatography, respectively. 37 
Size Fractionation of Hemolysate
Three different methods were used to establish the relative size of the component(s) in hemolysate responsible for increases in c-fos messenger (m)RNA. Before gel or membrane filtration, 1 vol of a 10 ϫ stock of the cell buffer (in mmol/L: NaCl 145, CaCl 2 2, KCl 3, MgCl 2 1, HEPES [pH 7.4] 10, glucose 10) was added to 9 vol of hemolysate. The sample was passed through a prepacked desalting column with an exclusion limit of 6 kD. Excluded high-molecularweight (HMW) and included low-molecular-weight (LMW) fractions were pooled and the concentrations of oxyhemoglobin and adenine nucleotides in the starting hemolysate solution and the two pools were determined. Equivalent amounts of oxyhemoglobin in the HMW fraction and ATP in the LMW fraction were used for a comparison with hemolysate for c-fos gene induction. High-and low-molecular-weight fractions were also prepared by membrane filtration in a centrifugation device with a nominal molecular weight cutoff of 10 kD. The level of residual LMW molecules in the retentate was reduced 67-fold by three additional centrifugation steps. The final retentate was adjusted to the original volume by adding buffer. Alternatively, an HMW fraction of hemolysate was prepared by precipitation at 5˚C with ammonium sulfate at 80% saturation. Precipitated protein was collected by centrifugation, recovered with water, and dialyzed overnight against two changes of 500 vol of cell buffer by using standard dialysis tubing (molecular weight cutoff of 14 kD).
Chromatography of Hemolysate
Hemolysate was fractionated by hydrophobic interaction chro-X. Wang, et al. , and 5 ϫ 10 Ϫ4 ng, respectively. matography. Hemolysate was adjusted to 2 mol/L ammonium sulfate, 40 mmol/L triethanolamine (pH 7.2), and applied to butylSepharose columns equilibrated with the same buffer. Unbound and weakly bound proteins were eluted with 1.5 mol/L ammonium sulfate. Hemoglobin was eluted with 1.2 mol/L ammonium sulfate and residual proteins were eluted with the buffer without ammonium sulfate. Proteins in unfractionated hemolysate and the three fractions were precipitated with ammonium sulfate and equilibrated with the cell buffer by dialysis. The recovered fractions were diluted to equal volumes and the hemoglobin concentrations determined by absorption values at 577 and 630 nm. 36 For the cell assay the fractions were compared with an equivalent concentration (based on original volumes) of the unfractionated hemolysate protein. The protein composition of the samples was monitored by sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) on 12% gels with Coomassie blue staining.
Quantitative Reverse Transcriptase-Polymerase Chain Reaction
Total RNA was isolated from cells by using the TRIZOL reagent. One microgram of RNA was used for complementary (c)DNA synthesis. 11 Competitor templates for quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) were prepared as described previously. 11 The PCR was performed using the specific primers shown in Table 1 . The PCR conditions were 94˚C for 1 minute, 60˚C for 1 minute, and 72˚C for 1 minute, for 34 cycles for immediate early genes and 94˚C for 1 minute, 57˚C for 1 minute, and 72˚C for 1 minute for 30 cycles for ␣-actin. After separation of PCR products on a 5% polyacrylamide gel, the amount of radioactivity in each specific product was determined directly by using commercially available software.
Statistical Analysis
To calculate changes in mRNA levels, the ratio of intensity of bands of products of cDNA and the corresponding internal standard DNA (cDNA/standard DNA) were determined first. Relative mRNA increases are comparisons with the level of mRNA at baseline. Values are expressed as the mean Ϯ standard error of the mean (SEM). All experiments were conducted in triplicate. Statistical analysis between groups was by Student's t-test. Significance was taken at a probability value less than 0.05.
Sources of Supplies and Equipment
The rat aortic smooth-muscle cells (clone A7r5) were obtained from American Type Culture Collection (Rockville, MD). Tissue culture reagents and ATP were purchased from Sigma Chemical Co. (St. Louis, MO), butyl-Sepharose from Pharmacia Biotech (Piscataway, NJ), and TRIZOL reagent from Gibco/BRL Life Technologies (Gaithersburg, MD). The Econo-Pac 10DG desalting column was obtained from BioRad (Hercules, CA) and the Centriprep-10 centrifugation device from Amicon (Beverly, MA). Phosphor Imager and Image Quant software, produced by Molecular Dynamics (Sunnyvale, CA) was used to determine radioactivity after separation of PCR products.
Hemosol Inc. (Toronto, Ontario, Canada) generously provided the highly purified oxyhemoglobin.
Results
Hemolysate Increases Immediate Early Gene mRNA
To test whether hemolysate induces expression of immediate early genes in smooth-muscle cells in vitro, confluent rat aorta cells were growth arrested by incubation with serum-free medium overnight, following which dog erythrocyte hemolysate (0.15 mmol/L hemoglobin) was added. After 15, 30, 60, or 120 minutes, the cells were harvested and total RNA was extracted. Competitive RT-PCR was used to detect c-fos, jun B, c-jun, and jun D mRNA. In unstimulated rat smooth-muscle cells, the c-fos mRNA level was the lowest among these four genes and the mRNA level of c-jun was the highest (Fig. 1) . The induction of c-fos, jun B, and c-jun started at 15 minutes and peaked at 60 minutes after incubation with hemolysate ( Fig. 2) . The level of induction of c-fos was the highest; the induction of c-jun was lower than that of c-fos and jun B. In contrast, no change in jun D expression was observed.
The dose response of immediate early genes was inves-
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Hemolysate and induction of gene expression tigated by incubating different amounts of hemolysate with smooth-muscle cells for 1 hour (Fig. 3) . For jun B and c-fos, the higher the concentration of hemolysate used, the higher the induction of the genes. The c-jun gene expression, however, was lower at the highest concentration of hemolysate than at the next lower concentration.
Components of Hemolysate That Increase Immediate Early Gene mRNA
Because oxyhemoglobin and ATP are possible spasmogens that cause vasospasm after SAH, the effect of each on c-fos expression was determined. The concentrations of ATP and oxyhemoglobin in hemolysate were determined and an equivalent amount of ATP or purified hemoglobin was incubated with rat smooth-muscle cells for different times (Fig. 4) . Both ATP and hemoglobin induced c-fos gene expression, but ATP induced less c-fos gene expression than hemoglobin (p = 0.12). Furthermore, these two components did not produce the level of c-fos induction that hemolysate did (p Ͻ 0.05). Another difference between the effect of hemolysate and the effects of ATP and hemoglobin was the time course of c-fos induction. Although c-fos mRNA expression in cells exposed to hemolysate remained high between 30 and 60 minutes, the gene induction caused by both ATP and hemoglobin peaked at 30 minutes and fell significantly at 60 minutes. It was apparent that another component or components in hemolysate influences the expression of this gene.
To determine the relative size of the component responsible for the majority of c-fos gene induction, hemolysate was fractionated with a desalting column. The HMW fraction (Ͼ 6 kD) induced significant c-fos gene expression (p Ͻ 0.05), whereas the LMW fraction (Ͻ 6 kD) did not (Fig. 5) . There was significantly greater c-fos induction with hemolysate, the HMW fraction, or the combination of HMW and LMW fractions, compared with the LMW fraction (p Ͻ 0.05, t-tests). In this experiment the large molecule fraction did not induce the full response of c-fos gene expression, as compared with hemolysate, although there was no statistical difference between the large molecule fraction and whole hemolysate (p = 0.07, t-test). When HMW components were prepared by the alternative methods of membrane filtration or ammonium sulfate precipitation, nearly complete recovery of the c-fos induction was obtained (data not shown). A small increase in c-fos mRNA with the small molecule fraction was sometimes observed, which was comparable to the relative activity of ATP as opposed to hemolysate. When the LMW fraction was added to the larger molecule fraction, however, no significant increase in c-fos gene expression was noted compared with the HMW fraction alone (Fig. 5) .
Because hemoglobin alone could not account for the induction of the c-fos gene in rat smooth-muscle cells caused by the HMW fraction of hemolysate, another method of protein fractionation was used in an attempt to characterize the compound(s) capable of inducing c-fos. Hemolysate proteins were separated into three fractions by hydrophobic interaction chromatography with butylSepharose in the presence of ammonium sulfate (Fig. 6) . Fractions 1 and 3 each contained proteins not present in the other fractions and each had one tenth as much hemoglobin as Fraction 2. Again, little gene induction activity was recovered in any single fraction (Fig. 7) . Fraction 3, which was eluted after hemoglobin, caused a slightly greater elevation of c-fos mRNA than the other two fractions. To confirm that the activity had not been lost during chromatography, the three fractions that had been generat- ed were recombined. No combination of any two fractions caused a significantly greater induction of c-fos; however, when all three were added together, the result was as great as the unfractionated protein mixture (Fig. 7 ). There were no statistically significant differences between the groups.
Discussion
We have demonstrated that the levels of expression of c-fos, jun B, and c-jun mRNA were increased when hemolysate was added to cultured rat aortic smooth-muscle cells, although the level of jun D mRNA was unchanged. The basal level of expression was greatest for c-jun and its induction by hemolysate was relatively less. The three immediate early genes whose expression was increased showed similar, but not identical, time courses in response to hemolysate. In dose-response experiments, c-fos and jun B expressions were elevated with increases in the concentration of hemolysate, whereas the c-jun mRNA level was lower at the highest concentration of hemolysate than at the next lower concentration. Multiple components of hemolysate, in addition to ATP and hemoglobin, contribute to the responses. This finding is important when considering the pathogenesis of vasospasm because consideration will have to be given to a role for compounds other than hemoglobin and ATP. 20, 23, 37, 38 
Increases in Immediate Early Genes in Smooth Muscle
These findings are similar to those observed in other smooth muscles. The same immediate early genes were increased (c-fos, jun B, c-jun) or not affected (jun D) when rat pulmonary artery smooth-muscle cells were treated with thrombin, a hypertrophic agent, or platelet-derived growth factor, which causes proliferation without hypertrophy. 29 In that study it was found that different pathways activate the c-fos and c-jun responses to these agents. The increase in c-fos mRNA was dependent on protein kinase C activation, but not on cyclic adenosine monophosphate (cAMP); whereas the c-jun response was not affected by inhibition of protein kinase C, but was decreased by inhibition of cAMP formation. The stability of c-jun mRNA is decreased when the intracellular calcium concentration increases. 32 At the highest dose of hemolysate in our studies, the signaling pathway(s) leading to c-fos and jun B expression may have raised calcium to a level at which there was increased degradation of c-jun mRNA or inhibition of the signaling pathway for c-jun mRNA expression.
What Component of Hemolysate Increases Immediate Early Genes?
Hemoglobin and ATP, two major components of hemolysate, have been shown to affect vascular cells and tissues in vitro. Adenosine triphosphate induces biphasic calcium increases in arterial endothelial and smooth-muscle cells through interaction with P 2 -purinergic receptors. 37, 38 Hemoglobin triggers vasoconstriction of cerebral arteries in vitro. 7 The combination of hemoglobin and an LMW (Ͻ 2 kD) fraction of hemolysate was found to result in more contraction of cerebral arteries than the sum of the effects of hemoglobin and the small molecules alone. that of hemolysate. The low levels of induction by ATP and hemoglobin and the earlier time courses of increased expression suggested that other components in hemolysate were contributing to immediate early gene expression. The possibility, however, that ATP interacts with hemoglobin or other HMW components to produce a greater response than that due to either component alone was not excluded. Three distinct MAP kinase cascades can cause an increase in c-fos gene expression in mammalian cells. 6 The extracellular-signal regulated kinase (ERK) signaling cascade transduces signals leading to cell proliferation and differentiation and is the best characterized pathway. The other two pathways are strongly stimulated by cellular stress and only weakly by mitogens. The three signaling cascades are not linear, but instead they function as a network. Each of these pathways has been shown to trigger the phosphorylation of 3pK, an MAP kinase-activated protein kinase. 18 Ludwig, et al., 18 found that activation of the ERK cascade resulted in a 3pK phosphorylation that peaked at 30 minutes, whereas activation of either of the two stress pathways caused a sustained phosphorylation that peaked between 30 and 60 minutes and was still high after 4 hours. These differences in timing are similar to the differences between the brief c-fos induction by ATP or hemoglobin, compared with the prolonged c-fos mRNA increase triggered by hemolysate, and indicate that hemolysate may activate at least one of the stress cascades in addition to the ERK cascade.
It has been observed that ATP can increase cytosolic calcium concentration and c-fos gene expression in cultured aortic smooth-muscle cells, but that these occur at different concentrations of ATP. 24 Changes in cytosolic calcium concentration require much less ATP (10 mol/ L) than c-fos gene expression (50 mol/L). We found that ATP did not induce c-fos gene expression until the ATP concentration level was approximately 40 mol/L. In another study, calcium influx induced immediate early gene expression in skeletal muscle cells. 1 It is possible that low concentrations of ATP could affect immediate early gene induction by HMW components of hemolysate through the effect of intracellular calcium levels on the activity of signaling kinases.
Because ATP and oxyhemoglobin produced only a small increase in c-fos mRNA, we fractionated hemolysate to characterize the active component. Most of the cfos-inducing activity of hemolysate was recovered in the HMW fraction. A relatively large size is also supported by the fact that the activity was recovered with hemoglobin and other proteins following ammonium sulfate precipitation and dialysis. What was surprising, however, was that on fractionation of the protein components, c-fos mRNA induction was lost. We tested a method, hydrophobic interaction chromatography, in which we separated hemolysate into three fractions, recovering all of the original protein. No one fraction nor any combination of two fractions caused the marked c-fos mRNA expression that was obtained by combining all three, suggesting that at least three components exert effects on the cells, which together cause increased expression of c-fos. The effects of the components alone may not be detectable because they are in low concentration or because synergy or cross talk between pathways activates downstream events necessary for transcription of the c-fos gene.
These findings are consistent with examples in other systems of a requirement for cofactors to induce c-fos expression. Using B and T lymphocyte cell lines, Kaptein, et al., 14 found that a cell-specific pattern of synergy between protein kinase C and calcium or cAMP signaling pathways was required for induction of c-fos. The hematopoietic growth factors, steel factor and granulocyte-macrophage colony-stimulating factor, induced at least an additive increase in c-fos mRNA expression in a human myeloid factor-dependent cell line. This required, in addition, the presence of low concentrations of serum, suggesting that at least three factors are acting in that system to promote the expression of c-fos. 9 The chromatography results together with the ATP-hemoglobin time study and the hemolysate dose-response results indicate the presence of multiple signaling components in hemolysate and the activation of multiple signaling pathways in the smooth-muscle cells. Because fractions had to be combined to recover the immediate early gene-inducing activity of hemolysate and only a limited number of cell samples could be tested in a single experiment, it was impractical to use this c-fos assay to characterize the relevant hemolysate proteins further.
Limitations of the Present Study
The interpretation of the results must take several factors into consideration. Dog hemolysate was applied to rat cells. Although immunological reactions would seem to be unlikely to occur in this cell-free system, the possibility that species differences caused some of the changes needs to be considered. This factor is not likely to be of major importance because hemoglobin, the major component of hemolysate, is not very immunogenic and because immediate early genes already have been shown to be induced in brain tissue after SAH in rats was caused by endovascular perforation or by cisternal blood injections, suggesting that species differences do not cause the effects. 10, 28 Aortic smooth-muscle cells were used to study vasospasm, a disease that affects cerebrovascular smooth muscle. Although all of the responses of aortic and cerebrovascular smooth-muscle cells to hemolysate have not been characterized to determine if they are the same, hemolysate has been reported to increase intracellular calcium in both types of cells, suggesting that there are similarities between the two types of cells. 8 Finally, questions can and have been raised about the relevance of changes in gene expression, intracellular calcium in cells in vitro, and even acute responses of arteries under isometric tension to compounds in blood. 35 With regard to changes in immediate early genes, Harada, et al., 10 have reported increased expression of c-fos and c-jun in brain tissue from rats that had SAH induced by endovascular perforation of the carotid bifurcation, suggesting that these responses do occur after SAH, at least in the brain itself. Nozaki and colleagues 28 reported similar induction of c-fos immunoreactivity in the brainstem of rats after cisternal injections of autologous blood. The use of multiple endpoints to investigate responses of vascular smooth muscle to hemolysate may be helpful because it is already known that some substances have differing effects on intracellular calcium and gene expression. For exam-ple, platelet-derived growth factor causes contraction of vascular smooth muscle under isometric tension, a response that would be expected to involve increased intracellular calcium; however, it increases immediate early gene expression in rat aortic smooth-muscle cells without elevating intracellular calcium. 12, 27 Both responses may be important in the pathophysiological responses to this cytokine.
Relation to Vasospasm and Vascular Diseases
The presence of erythrocytes is responsible for cerebral vasospasm and associated morphological changes of the affected region of the artery, but the molecules and pathways involved are uncertain. 7, 20, 25 This work suggests that there are multiple molecules in hemolysate that have a multitude of effects on vascular cells. Other studies have suggested that hemoglobin acts with other compounds in the erythrocyte to contract arteries in vitro. 3 At present there is no evidence to relate changes in immediate early gene expression directly to vasospasm; however, the finding that multiple erythrocyte components are responsible for the immediate early gene response fits with the observation that, although hemoglobin can cause vasospasm when applied to cerebral arteries in vivo for days, the spasm is seldom as severe as that caused by whole blood or erythrocytes alone. 5, 19, 23, 25 This may be due to an alteration in the release of hemoglobin or because other compounds in the erythrocytes are important. In an attempt to isolate a compound with the ability to contract fibroblastpopulated collagen lattices from the cerebrospinal fluid of patients with SAH, this compound was found to have a molecular weight of less than 6 kD. 30 Finally, we have studied the effects of incubated erythrocyte hemolysates and hemoglobins on intracellular calcium in smooth-muscle cells. 8 The results also showed that there are multiple factors in incubated erythrocyte hemolysate that must interact to elevate intracellular calcium.
Many of the same morphological changes in arteries during cerebral vasospasm are also seen in proliferative angiopathies such as atherosclerosis and hypertension. It has been proposed that atherosclerotic lesions are related to red-cell fragmentation due to shear forces upstream of the affected site. 13 In this situation the interior arterial surface is exposed to hemolysate with tissue responses similar to those associated with SAH and cerebral vasospasm. Erythrocyte lysis may release a set of components that alters gene expression in arterial smooth-muscle cells, leading to altered contractile responses as well as to cellular hypertrophy and/or proliferation. Indeed, maneuvers that prevent induction of immediate early gene expression are already being tested for their ability to prevent restenosis after experimental balloon angioplasty. 33 The relationship between immediate early gene expression and diseases such as vasospasm and atherosclerosis needs to be investigated further because it may represent a first step in defining pathways that lead to processes important in the pathogenesis of these conditions.
